Searching PubMed for “Clinical Trial” and checking full-text availability…
for “Clinical Trial” · Showing 8,221–8,240 · 2182 ms
Rickels K, Gordon P E, Jenkins B W, +5 more·Diseases of the nervous system
Abstract not available
Sheskin J, Sagher F·International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association
Abstract not available
Klett C J, Hollister L E, Caffey E M, +1 more·Archives of general psychiatry
Abstract not available
Blackard C E, Doe R P, Mellinger G T, +1 more·Cancer
Abstract not available
Novak E, Wagner J G, Lamb D J·Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology
Abstract not available
Hedstrand U·Scandinavian journal of respiratory diseases
Abstract not available
Carter J P, Grivetti L E, Davis J T, +8 more·The American journal of clinical nutrition
Abstract not available
Schoger G A·Arzneimittel-Forschung
Abstract not available
Bojanovský J, Hánysová Z·Activitas nervosa superior
Abstract not available
Seifert E, Dittrich H·Medizinische Klinik
Abstract not available
The Medical letter on drugs and therapeutics
Abstract not available
Birnie E, Monincx W M, Zondervan H A, +2 more·Journal of clinical epidemiology
Valuations may be sensitive to biases, especially if elicited alongside randomized clinical trials. We investigated the construction of valuations assigned by women who entered a randomized clinical trial and were allocated to in-hospital or domiciliary monitoring. Women assigned valuations (0-10 visual analogue scale)…
Lin J, Shiu W, Leung W T, +4 more·Cancer chemotherapy and pharmacology
A phase II study of high-dose ifosfamide in hepatocellular carcinoma was conducted among 17 Chinese patients. The dose of ifosfamide used was 2.5 g/m2 daily given as a continuous infusion for 5 days. In all, 15 patients were evaluable for tumour response. There was no complete or partial responder. The treatment was we…
Hachen H J·The Journal of urology
In a 6-month, double-blind, placebo-controlled clinical trial with cross-over, we investigated the efficacy and tolerance of an orally administered bacterial extract in 70 spinal cord injury patients with chronic lower urinary tract infections. In the treated patients, compared to those given placebo, there was a stati…
Bell K M, Plon L, Bunney W E, +1 more·The American journal of psychiatry
The antidepressant properties of S-adenosylmethionine, an endogenous methyl donor, were studied in inpatients who met the DSM-III criteria for major depression. Nine patients given intravenous S-adenosylmethionine and nine given low oral doses of imipramine were compared in a double-blind design for 14 days. The S-aden…
Baker R S, Chole R A·Archives of otolaryngology--head & neck surgery
Purulent otorrhea is the most common complication of tympanostomy with tube placement. Some authors report an incidence of over 30%. We have evaluated topical gentamicin solution for prophylaxis in a controlled, randomized, prospective clinical trial. Nine patients of the 102 in the study developed otorrhea in the firs…
Grosvenor T, Perrigin D M, Perrigin J, +1 more·American journal of optometry and physiological optics
In a randomized clinical trial designed to test the efficacy of bifocal lenses for the control of juvenile myopia, each of 207 children between the ages of 6 and 15 years wore single vision lenses, +1.00 D add bifocals, or +2.00 D add bifocals for a period of 3 years. For the 124 subjects who completed the study, the m…
Sachar D B, Rubin K P, Gumaste V·The American journal of gastroenterology
To evaluate the efficacy of levamisole in the treatment of Crohn's disease, 19 patients were entered into a long-term, randomized, double-blind, placebo-controlled clinical trial. Seventeen patients (eight in the levamisole group and nine in the placebo group) completed the initial treatment arm of the study. Assessmen…
Kolakowska T, Gadhvi H, Molyneux S·International clinical psychopharmacology
The reports of hyperserotonaemia in chronic schizophrenics and the indications that fenfluramine, a serotonin-releasing drug, may be of therapeutic value in hyperserotonaemic autistic children, were the rationale for this clinical trial. Fenfluramine was administered to 4 treatment-resistant chronic schizophrenic in-pa…
Mongin-Long D, Chabrol B, Baude C, +4 more·British journal of anaesthesia
Atracurium was given to 30 patients with terminal chronic renal insufficiency, in two regimens. Group I (20 patients) received a single dose of 0.6 mg kg-1 and group II (10 patients), received one or several injections of 0.2 mg kg-1. Tracheal intubation was performed with ease in all patients 3 min after the injection…